Skip to main content
SpringerLink
Log in

Emicizumab: positive AE signals for arthralgia and injection-site pain, but also for some serious AEs

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Wei L, et al. Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database. International Journal of Clinical Pharmacy : 27 Feb 2023. Available from: URL: https://doi.org/10.1007/s11096-022-01514-4

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Emicizumab: positive AE signals for arthralgia and injection-site pain, but also for some serious AEs. Reactions Weekly 1950, 9 (2023). https://doi.org/10.1007/s40278-023-36406-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-36406-0

Search

Navigation